1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with neurotensin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chong, PN; de Ceballos, ML; Jenner, P; Marsden, CD; Rose, S; Taylor, MD | 1 |
Allen, JM; Close, SP; Cross, AJ; Crow, TJ; Ghatei, MA; Marriott, AS; McGregor, GP; Pay, S; Tyers, MB; Yeats, JC | 1 |
Bédard, P; Gauthier, S; Quirion, R; Welner, S | 1 |
Bédard, PJ; Di Paolo, T; Falardeau, P; Goulet, M; Grondin, R; Morissette, M; Rostène, W | 1 |
Araki, T; Fujihara, K; Itoyama, Y; Nagasawa, H; Tanji, H | 1 |
Gudasheva, TA; Kucheryanu, VG; Lutsenko, VK; Vukolova, MN | 1 |
6 other study(ies) available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and neurotensin
Article | Year |
---|---|
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Basal Ganglia; Biogenic Monoamines; Callithrix; Caudate Nucleus; Dopamine; Enkephalin, Leucine; Enkephalin, Methionine; Female; Globus Pallidus; Homovanillic Acid; Male; Neuropeptides; Neurotensin; Putamen; Reference Values; Sincalide; Substance P | 1991 |
Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Chemistry; Callitrichinae; Cholecystokinin; Disease Models, Animal; Dopamine; Female; Kidney; Male; Neurotensin; Parkinson Disease, Secondary; Pyridines; Substance P; Vasoactive Intestinal Peptide | 1986 |
Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Autoradiography; Brain; Female; Humans; Macaca; Macaca fascicularis; Male; Middle Aged; Neurotensin; Pyridines; Receptors, Neurotensin; Receptors, Neurotransmitter; Subcellular Fractions | 1987 |
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Autoradiography; Binding Sites; Carrier Proteins; Caudate Nucleus; Denervation; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Imidazoles; In Situ Hybridization; Macaca fascicularis; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Neurotensin; Piperidines; Putamen; Receptors, Dopamine; Receptors, Neurotensin; RNA, Messenger; Substantia Nigra | 1999 |
Alteration of neurotensin receptors in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Male; Mazindol; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurotensin; Neurotoxins; Parkinson Disease; Receptors, Neurotensin; Substantia Nigra | 1999 |
Dipeptide analog of neurotensin active site prevents the development of experimental Parkinson's syndrome in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Cell Membrane; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Neurotensin; Neurotoxins; Parkinson Disease, Secondary; Synaptosomes; Time Factors | 2003 |